GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Star Bulk Carriers Corp. (SBLK) [hlAlert]

Rating:
Mkt Outperform
SBLK
down 95.73 %

Star Bulk Carriers Corp. (SBLK) rated Mkt Outperform with price target $3.20 by Rodman & Renshaw

Posted on: Friday,  Sep 24, 2010  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Star Bulk Carriers Corp. (NASDAQ: SBLK) on 09/24/2010. Previously Rodman & Renshaw rated Mkt Outperform Star Bulk Carriers Corp.
(NASDAQ: SBLK) on 10/01/2009., when the stock price was $52.50. Since then, Star Bulk Carriers Corp. has lost 95.73% as of 01/26/2016's recent price of $2.24.
If you would have followed the previous Rodman & Renshaw's recommendation on SBLK, you would have lost 95.73% of your investment in 2308 days.

Star Bulk Carriers Corp. (Star Bulk) is an international company providing worldwide transportation of drybulk commodities through its vessel-owning subsidiaries for a range of customers of major and minor bulk cargoes including iron ore, coal, grain, cement and fertilizer. As of December 31, 2008, the Company owns and operates a fleet of 12 vessels consisting of four Capesize and eight Supramax drybulk carriers with an average age of ten years and a combined cargo carrying capacity of approximately 1.1 million dwt. Star Bulk?s fleet carries a variety of drybulk commodities including coal, iron ore, and grains, or major bulks, as well as bauxite, phosphate, fertilizers and steel products, or minor bulks. It charters all of its vessels on medium- to long-term time charters with terms of approximately 1 to 5 years, other than the Star Alpha, which is employed under a contract of affreightment (COA).

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/24/2010 8:25 AM Buy
None
42.90 48.00
as of 12/31/2010
1 Week down  -0.36 %
1 Month down  -5.57 %
3 Months down  -4.91 %
1 YTD down  -3.90 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/1/2009 9:25 AM Buy
None
52.50 82.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy